Last Updated: July 07, 2024
gsk.ai has 4 NS records, 1 A records, 0 AAAA records, 1 MX records, and 0 TXT records. Name servers for gsk.ai are ns-1601.awsdns-08.co.uk, ns-87.awsdns-10.com, ns-999.awsdns-60.net, ns-1070.awsdns-05.org. A records for gsk.ai are 34.117.76.215. MX records that process @gsk.ai email are mail.imgw.com. We have observed gsk.ai to have 2 subdomains. A subdomain count of 2 is considered a small digital footprint. As of July 07, 2024, gsk.ai does not have any threat intelligence reports of concern.
Search DigitalStakeout ASI to find another asset.
34.117.76.215
No DNS AAAA records
mail.imgw.com
ns-1601.awsdns-08.co.uk
ns-87.awsdns-10.com
ns-999.awsdns-60.net
ns-1070.awsdns-05.org
No DNS TXT records
gsk.ai has 2 subdomains in our inventory.
Microsoft-IIS/10.0
United States
{"data":{"cert_index":13078772,"cert_link":"https:\/\/ct.googleapis.com\/logs\/eu1\/xenon2025h1\/ct\/v1\/get-entries?start=13078772&end=13078772","leaf_cert":{"all_domains":["api.carerhood.gsk.com","www.pricedisclosure.gsk.com","services.gsk-chus.com","vivermaisgsk.com.br","www.dovato.ca","plus.gsk.co.uk","cursosenlinea-gt.gsk.com","stoprsv.sg","www.formularycoverage.gsk.com","paso.com.uy","www.pharmacy.gsk.co.uk","www.services.gsk-chus.com","www.plus.gsk.co.uk","www.gsk.ai","taijouhoushin-yobou.jp","stayconnectedpro.com","formularycoverage.gsk.com","www.stayconnectedpro.com","www.gsk-applicationservices.com","viajarsano.com","www.cuidatedelameningitis.cl","recuperatunormalidad.gsk.com","softlaunch-iis.gskinternet.com","www.gskkompendium.cz","www.cursosenlinea-sv.gsk.com","dovato.ca","severeasthma.co.nz","www.infanrix.kr","www.laprevenzionenonhaeta.it","www.missingb.it","valtrexpatientprogram.ca","optime.gsk.es","www.cancerovaireconseils.fr","www.api.carerhood.gsk.com","ilmielomamultiploetu.it","infanrix.kr","www.optime.gsk.es","gsk.ai","cuidatedelameningitis.cl","missingb.it","www.tools.health.gsk.hk","www.ideal.gsk.co.uk","tools.gskpro.ph","www.vivermaisgsk.com.br","www.cursosenlinea-rd.gsk.com","gsk-applicationservices.com","cursosenlinea-sv.gsk.com","cursosenlinea-pa.gsk.com","www.rakszyjki.pl","www.xn--rs-og4ah0h0n.jp","tools.health.gsk.hk","superv.es","www.tools.gskpro.ph","gskamo.com","www.cursosenlinea-pa.gsk.com","www.myvaccinationhub.in","www.paso.com.uy","gskkompendium.cz","www.valtrexpatientprogram.ca","uruguaycontralameningitis.com.uy","www.with-sle.jp","laprevenzionenonhaeta.it","rakszyjki.pl","www.superv.es","www.iotiproteggero.it","www.recuperatunormalidad.gsk.com","survey.gsk.com","mars17study.com","cursosenlinea-rd.gsk.com","vivermais50.com.br","www.taijouhoushin-yobou.jp","www.stoprsv.sg","with-sle.jp","www.survey.gsk.com","www.gskamo.com","www.uruguaycontralameningitis.com.uy","iotiproteggero.it","www.severeasthma.co.nz","cancerovaireconseils.fr","www.vivermais50.com.br","hainyo-onayami.jp","pharmacy.gsk.co.uk","www.viajarsano.com","www.cursosenlinea-gt.gsk.com","www.ilmielomamultiploetu.it","pricedisclosure.gsk.com","ideal.gsk.co.uk","www.mars17study.com","xn--rs-og4ah0h0n.jp","www.hainyo-onayami.jp","myvaccinationhub.in"],"extensions":{"authorityInfoAccess":"OCSP - URI:http:\/\/ocsp.sectigo.com\nCA Issuers - URI:http:\/\/crt.sectigo.com\/SectigoRSAOrganizationValidationSecureServerCA.crt\n","authorityKeyIdentifier":"keyid:17:D9:D6:25:27:67:F9:31:C2:49:43:D9:30:36:44:8C:6C:A9:4F:EB\n","basicConstraints":"CA:FALSE","certificatePolicies":"Policy: 2.23.140.1.2.2\nPolicy: 1.3.6.1.4.1.6449.1.2.1.3.4\n CPS: https:\/\/sectigo.com\/CPS","crlDistributionPoints":"Full Name:\n URI:http:\/\/crl.sectigo.com\/SectigoRSAOrganizationValidationSecureServerCA.crl","ctlPoisonByte":true,"extendedKeyUsage":"TLS Web server authentication, TLS Web client authentication","keyUsage":"Digital Signature, Key Encipherment","subjectAltName":"DNS:xn--rs-og4ah0h0n.jp, DNS:www.xn--rs-og4ah0h0n.jp, DNS:www.with-sle.jp, DNS:www.vivermaisgsk.com.br, DNS:www.vivermais50.com.br, DNS:www.viajarsano.com, DNS:www.valtrexpatientprogram.ca, DNS:www.uruguaycontralameningitis.com.uy, DNS:www.tools.health.gsk.hk, DNS:www.tools.gskpro.ph, DNS:www.taijouhoushin-yobou.jp, DNS:www.survey.gsk.com, DNS:www.superv.es, DNS:www.stoprsv.sg, DNS:www.stayconnectedpro.com, DNS:www.severeasthma.co.nz, DNS:www.services.gsk-chus.com, DNS:www.recuperatunormalidad.gsk.com, DNS:www.rakszyjki.pl, DNS:www.pricedisclosure.gsk.com, DNS:www.plus.gsk.co.uk, DNS:www.pharmacy.gsk.co.uk, DNS:www.paso.com.uy, DNS:www.optime.gsk.es, DNS:www.myvaccinationhub.in, DNS:www.missingb.it, DNS:www.mars17study.com, DNS:www.laprevenzionenonhaeta.it, DNS:www.iotiproteggero.it, DNS:www.infanrix.kr, DNS:www.ilmielomamultiploetu.it, DNS:www.ideal.gsk.co.uk, DNS:www.hainyo-onayami.jp, DNS:www.gskkompendium.cz, DNS:www.gskamo.com, DNS:www.gsk.ai, DNS:www.gsk-applicationservices.com, DNS:www.formularycoverage.gsk.com, DNS:www.dovato.ca, DNS:www.cursosenlinea-sv.gsk.com, DNS:www.cursosenlinea-rd.gsk.com, DNS:www.cursosenlinea-pa.gsk.com, DNS:www.cursosenlinea-gt.gsk.com, DNS:www.cuidatedelameningitis.cl, DNS:www.cancerovaireconseils.fr, DNS:www.api.carerhood.gsk.com, DNS:with-sle.jp, DNS:vivermaisgsk.com.br, DNS:vivermais50.com.br, DNS:viajarsano.com, DNS:valtrexpatientprogram.ca, DNS:uruguaycontralameningitis.com.uy, DNS:tools.health.gsk.hk, DNS:tools.gskpro.ph, DNS:taijouhoushin-yobou.jp, DNS:survey.gsk.com, DNS:superv.es, DNS:stoprsv.sg, DNS:stayconnectedpro.com, DNS:severeasthma.co.nz, DNS:services.gsk-chus.com, DNS:recuperatunormalidad.gsk.com, DNS:rakszyjki.pl, DNS:pricedisclosure.gsk.com, DNS:plus.gsk.co.uk, DNS:pharmacy.gsk.co.uk, DNS:paso.com.uy, DNS:optime.gsk.es, DNS:myvaccinationhub.in, DNS:missingb.it, DNS:mars17study.com, DNS:laprevenzionenonhaeta.it, DNS:iotiproteggero.it, DNS:infanrix.kr, DNS:ilmielomamultiploetu.it, DNS:ideal.gsk.co.uk, DNS:hainyo-onayami.jp, DNS:gskkompendium.cz, DNS:gskamo.com, DNS:gsk.ai, DNS:gsk-applicationservices.com, DNS:formularycoverage.gsk.com, DNS:dovato.ca, DNS:cursosenlinea-sv.gsk.com, DNS:cursosenlinea-rd.gsk.com, DNS:cursosenlinea-pa.gsk.com, DNS:cursosenlinea-gt.gsk.com, DNS:cuidatedelameningitis.cl, DNS:cancerovaireconseils.fr, DNS:api.carerhood.gsk.com, DNS:softlaunch-iis.gskinternet.com","subjectKeyIdentifier":"E2:41:C2:9A:1B:4A:57:52:75:0A:ED:77:21:7F:43:32:26:2B:04:C4"},"fingerprint":"BD:80:61:AF:D8:01:EE:63:2F:44:3D:22:F8:C6:46:E2:96:07:2D:6A","issuer":{"C":"GB","CN":"Sectigo RSA Organization Validation Secure Server CA","L":"Salford","O":"Sectigo Limited","OU":null,"ST":"Greater Manchester","aggregated":"\/C=GB\/CN=Sectigo RSA Organization Validation Secure Server CA\/L=Salford\/O=Sectigo Limited\/ST=Greater Manchester","emailAddress":null},"not_after":1737071999,"not_before":1705449600,"serial_number":"C35262B20897778179992CC370C8CA77","signature_algorithm":"sha256, rsa","subject":{"C":"GB","CN":"softlaunch-iis.gskinternet.com","L":null,"O":"GlaxoSmithKline Holdings Ltd","OU":null,"ST":"Middlesex","aggregated":"\/C=GB\/CN=softlaunch-iis.gskinternet.com\/O=GlaxoSmithKline Holdings Ltd\/ST=Middlesex","emailAddress":null}},"seen":1705510067.982237,"source":{"name":"Google 'Xenon2025h1' log","url":"https:\/\/ct.googleapis.com\/logs\/eu1\/xenon2025h1\/"},"update_type":"PrecertLogEntry"},"message_type":"certificate_update"}